Limited time75% off all plans
Get the app

On this page

Lymphoma Basics - Tiny Tumors, Big Trouble

  • Malignant neoplasms of lymphocytes or their precursors, typically arising in lymphoid tissues.
  • Two major categories: Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL).
  • HL: Characterized by presence of Reed-Sternberg (RS) cells; often localized, contiguous spread.
  • NHL: More common, diverse group of B-cell, T-cell, NK-cell origin; often disseminated.
  • Staging: Ann Arbor classification (Stages I-IV, with A/B symptoms). Reed-Sternberg cell in Hodgkin Lymphoma

⭐ Hodgkin Lymphoma classically presents with a bimodal age distribution, peaking at 15-35 years and again at >50 years anco

Hodgkin's Lymphoma - Reed's Rogue Roster

⭐ Reed-Sternberg (RS) cells are pathognomonic, appearing as large cells with bilobed or multiple nuclei and prominent eosinophilic nucleoli ("owl-eye" appearance).

  • Age: Bimodal distribution (15-35 years and >50 years).
  • Presentation: Painless lymphadenopathy (often cervical/supraclavicular), contiguous spread. "B" symptoms: unexplained fever, drenching night sweats, weight loss >10% over 6 months.
  • 📌 RS Cell "Rogues": Owl eyes, With Lacunar variants (Nodular Sclerosis type), CD30 & CD15 positive.
  • Key Subtypes:
    • Nodular Sclerosis (most common, young females, good prognosis)
    • Mixed Cellularity (EBV association, intermediate prognosis)
    • Lymphocyte-Rich (best prognosis)
    • Lymphocyte-Depleted (worst prognosis, HIV association)

Reed-Sternberg cells in Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma - Nasty Network Nuisance

  • Aggressive lymphoid malignancies, commoner than HL in kids. Often extranodal.
  • Key Subtypes & Features:
    • Burkitt Lymphoma (BL):
      • Aggressive B-cell. Endemic (jaw, EBV) & Sporadic (abdomen).
      • Histology: "Starry sky" appearance.
      • Genetics: t(8;14) translocation involving MYC gene.

      ⭐ Burkitt Lymphoma is the fastest growing human tumor and associated with t(8;14).

    • Lymphoblastic Lymphoma (LBL):
      • Mostly T-cell (85-90%).
      • Mediastinal mass (SVC risk), LAD. Can → ALL.
    • Diffuse Large B-cell Lymphoma (DLBCL):
      • Aggressive B-cell type.
    • Anaplastic Large Cell Lymphoma (ALCL):
      • ALK+ (t(2;5)). Nodes, skin, bone. 'Hallmark' cells.
  • Clinical Presentation: Rapid mass (abdomen, mediastinum, H&N), LAD. B-symptoms < HL. Emergencies (SVC, TLS) common.
  • Diagnosis & Management:
  • 📌 Tx: CHOP-like chemo + Rituximab (B-cell). CNS prophylaxis vital.

Clues & Confirmation - Spotting Sneaky Cells

  • Clinical Suspicion:
    • Painless, firm lymphadenopathy (rubbery, matted).
    • B-symptoms: Fever (>38°C), drenching night sweats, weight loss (>10%/6mo). 📌 "B" for Bad prognosis.
    • Mediastinal mass (HL, T-LBL): cough, dyspnea.
    • Abdominal symptoms (Burkitt): pain, mass.
  • Diagnostic Workup:
    • Labs: CBC, ESR, LDH (↑), Uric acid.
    • Imaging: CXR, CT (staging), PET-CT (FDG-avid).
    • Biopsy is KEY:

      ⭐ Excisional lymph node biopsy is crucial for accurate diagnosis and subtyping.

    • Bone marrow & CSF analysis (staging, high-risk NHL).
    • HPE & IHC:
      • HL: Reed-Sternberg cells (CD30+, CD15+).
      • NHL: Specific markers (e.g., Burkitt: t(8;14), Starry sky; Lymphoblastic: TdT+).

High‑Yield Points - ⚡ Biggest Takeaways

  • Hodgkin Lymphoma (HL): Reed-Sternberg cells are pathognomonic. Nodular Sclerosis is the most common subtype. Presents with painless lymphadenopathy.
  • Non-Hodgkin Lymphoma (NHL): More common, aggressive. Key types: Burkitt (t(8;14), starry sky, abdominal/jaw mass) & Lymphoblastic (mediastinal mass).
  • B symptoms (fever, night sweats, weight loss) are important prognostic factors, especially in HL.
  • Ann Arbor staging for HL. NHL often has extranodal involvement and rapid dissemination.
  • Chemotherapy is the primary treatment; radiotherapy is used cautiously to minimize late effects.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE